Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $11.49, but opened at $10.94. Anbio Biotechnology shares last traded at $11.0250, with a volume of 1,799 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Anbio Biotechnology Price Performance

The firm has a fifty day simple moving average of $22.17.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.